Non-exclusive rebate agreement for medicinal products containing Umeclidinium + Vilanterol for the period 01/09/2026–31/08/2028

Summary

This tender concerns the conclusion of a rebate agreement for medicinal products containing the active substance Umeclidinium + Vilanterol for the period 01/09/2026–31/08/2028. DAK-Gesundheit intends to conclude non-exclusive rebate agreements with as many interested pharmaceutical companies as possible for the medicinal products to be named by the bidder in the contract annex. This is a supply contract for medicinal products, and the exact participation and submission requirements must be checked in the tender documents.